Form D · Biotechnology

Volpara Health Technologies Ltd

Wellington, Q2 · CIK 0001685294

Offering snapshot reported Nov 22, 2016 · SEC filing

Reported sold: Yet to sell
Investors reported: 0
Minimum accepted: $0
First sale: Yet to occur

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Source
Nov 22, 2016	Amendment	Yet to sell	No comparison	SEC filing
Nov 2, 2016	Amendment	Yet to sell	No comparison	SEC filing
Sep 28, 2016	Initial	Yet to sell	No comparison	SEC filing

Offering details

Securities: Equity, Option to acquire, Security to be acquired
Exemptions: 05, 06b, 4a5
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-271409

Amount is approximate. Consideration for the securities will be paid in New Zealand dollars in some cases and Australian dollars in others, and will fluctuate with changes in currency exchange rates.

Source: Form D, filed Nov 22, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Roger Allen	Director
John Michael Brady	Director
John Flower Diddams	Director
Mark Koeniguer	Executive
Brian Robert Leighs	Executive
Julian Marshall	Executive
David Murry	Executive
John Pavlidis	Director
Lynette Mary Swinburne	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

Level 12, 86 Victoria St.
Wellington, Q2, 6011